1. Home
  2. Labeler Index
  3. Pfizer Laboratories Div Pfizer Inc
  4. 0069-0600
  5. NDC Package Code: 0069-0600-10 Penbraya

NDC Package 0069-0600-10 Penbraya

Meningococcal Groups A,B,C,W,And Y Vaccine Kit - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-0600-10
Package Description:
10 KIT in 1 CARTON / 1 KIT in 1 KIT (0069-0600-99) * .5 mL in 1 VIAL, GLASS (0069-0271-01) * .5 mL in 1 SYRINGE (0069-0332-01)
Product Code:
0069-0600
Proprietary Name:
Penbraya
Non-Proprietary Name:
Meningococcal Groups A, B, C, W, And Y Vaccine
Usage Information:
PENBRAYA is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y. PENBRAYA is approved for use in individuals 10 through 25 years of age.
11-Digit NDC Billing Format:
00069060010
NDC to RxNorm Crosswalk:
  • RxCUI: 2670559 - Meningococcal (Groups A,B,C,Y and W-135) Polysaccharide Tetanus Toxoid Conjugate Vaccine 0.5 ML Injection
  • RxCUI: 2670559 - 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML Injection
  • RxCUI: 2670559 - Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.06 MG / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.06 MG / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 5 MCG / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 5 MCG per 0.5 ML Injection
  • RxCUI: 2670566 - PENBRAYA vaccine 0.5 ML Injection
  • RxCUI: 2670566 - 0.5 ML Neisseria meningitidis serogroup A capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 A05 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup B recombinant LP2086 B01 protein variant antigen 0.12 MG/ML / Neisseria meningitidis serogroup C capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup W-135 capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML / Neisseria meningitidis serogroup Y capsular polysaccharide tetanus toxoid protein conjugate vaccine 0.01 MG/ML Injection [Penbraya]
Product Type:
Vaccine
Labeler Name:
Pfizer Laboratories Div Pfizer Inc
Dosage Form:
Kit - A packaged collection of related material.
Sample Package:
No
FDA Application Number:
BLA125770
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
11-27-2023
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
0069-0600-011 KIT in 1 CARTON / 1 KIT in 1 KIT (0069-0600-99) * .5 mL in 1 VIAL, GLASS (0069-0271-01) * .5 mL in 1 SYRINGE (0069-0332-01)
0069-0600-055 KIT in 1 CARTON / 1 KIT in 1 KIT (0069-0600-99) * .5 mL in 1 VIAL, GLASS (0069-0271-01) * .5 mL in 1 SYRINGE (0069-0332-01)

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0069-0600-10?

The NDC Packaged Code 0069-0600-10 is assigned to a package of 10 kit in 1 carton / 1 kit in 1 kit (0069-0600-99) * .5 ml in 1 vial, glass (0069-0271-01) * .5 ml in 1 syringe (0069-0332-01) of Penbraya, a vaccine label labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is kit and is administered via form.

Is NDC 0069-0600 included in the NDC Directory?

Yes, Penbraya with product code 0069-0600 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on November 27, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 0069-0600-10?

The 11-digit format is 00069060010. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20069-0600-105-4-200069-0600-10